Sildenafil Tablet, Film Coated
Product Images NDC 68071-3954

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)

Chemical structure of sildenafil showing its molecular framework including the pyrazolo and piperazine rings along with sulfonamide and carboxyl groups, as depicted in the image.*

FDA Label Image

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)

A line graph showing change from baseline in meters over study weeks 4, 8, and 12 for placebo and three Sildenafil dose groups (20 mg, 40 mg, and 80 mg, each taken three times daily). The y-axis represents change from baseline in meters, the x-axis shows the week of study. Data points include error bars indicating variability.*

FDA Label Image

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)

A forest plot showing placebo-corrected changes in 6-minute walk distance (in meters) for Sildenafil 20 mg taken three times daily, stratified by baseline walk distance, PAH etiology, PH functional class, gender, age, mean pulmonary arterial pressure (PAP), and pulmonary vascular resistance index (PVRI). The chart includes subgroup sample sizes and confidence intervals for each category.*

FDA Label Image

Pi Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 09)

FDA Label Image

Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 10)

FDA Label Image

Pdp (68071 3954 9)

Label for Sildenafil 20 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets. It includes NDC 68071-3954-9 and states the product is for prescription use only. The label shows manufacturing information by Torrent Pharmaceuticals Ltd., India, and includes dosage instructions and warnings to keep out of reach of children.*

FDA Label Image

Figure-1 (Figure 1)

A forest plot chart showing fold changes and 90% confidence intervals in AUC and Cmax for various interacting drugs taken with Sildenafil. The chart includes drugs like Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, with recommendations ranging from no dose adjustment to coadministration not recommended.*

FDA Label Image

Figure-2 (Figure 2)

A forest plot chart showing fold change and 90% confidence intervals for various drugs interacting with sildenafil. The chart presents fold change values for different parameters such as INR AUC, INR Cmax, bleeding time, AUC, and Cmax of the interacting drugs. Recommendations include no dose adjustment for most drugs, with coadministration not recommended for bosentan and ritonavir. Values are plotted relative to the interacting drug alone, with a vertical solid line at x=1 as a reference.*

FDA Label Image

Figure-5 (Figure 5)

A line graph comparing the percentage of subjects without a clinically worsening event over time from randomization, with one line representing Sildenafil and another representing placebo. The x-axis shows days from randomization up to 112, and the y-axis shows the percentage from 0 to 100. Sildenafil maintains a higher percentage over time compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.